These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 2902215

  • 1. Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
    Stone DM, Johnson M, Hanson GR, Gibb JW.
    J Pharmacol Exp Ther; 1988 Oct; 247(1):79-87. PubMed ID: 2902215
    [Abstract] [Full Text] [Related]

  • 2. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.
    Gibb JW, Stone DM, Stahl DC, Hanson GR.
    NIDA Res Monogr; 1987 Oct; 76():316-21. PubMed ID: 2449619
    [Abstract] [Full Text] [Related]

  • 3. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
    Schmidt CJ, Abbate GM, Black CK, Taylor VL.
    J Pharmacol Exp Ther; 1990 Nov; 255(2):478-83. PubMed ID: 1978728
    [Abstract] [Full Text] [Related]

  • 4. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
    [Abstract] [Full Text] [Related]

  • 5. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.
    Johnson M, Letter AA, Merchant K, Hanson GR, Gibb JW.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):977-82. PubMed ID: 2472482
    [Abstract] [Full Text] [Related]

  • 6. Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine.
    Schmidt CJ, Black CK, Taylor VL.
    Eur J Pharmacol; 1990 May 31; 181(1-2):59-70. PubMed ID: 1974858
    [Abstract] [Full Text] [Related]

  • 7. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
    Johnson M, Mitros K, Stone DM, Zobrist R, Hanson GR, Gibb JW.
    J Pharmacol Exp Ther; 1992 May 31; 261(2):586-91. PubMed ID: 1374469
    [Abstract] [Full Text] [Related]

  • 8. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.
    Schmidt CJ.
    J Pharmacol Exp Ther; 1987 Jan 31; 240(1):1-7. PubMed ID: 2433425
    [Abstract] [Full Text] [Related]

  • 9. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW, Wing LL, Geyer MA.
    J Pharmacol Exp Ther; 1990 Aug 31; 254(2):456-64. PubMed ID: 1974635
    [Abstract] [Full Text] [Related]

  • 10. Role of dopamine in the neurotoxic effects of methamphetamine.
    Schmidt CJ, Ritter JK, Sonsalla PK, Hanson GR, Gibb JW.
    J Pharmacol Exp Ther; 1985 Jun 31; 233(3):539-44. PubMed ID: 2409267
    [Abstract] [Full Text] [Related]

  • 11. Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.
    Johnson M, Elayan I, Hanson GR, Foltz RL, Gibb JW, Lim HK.
    J Pharmacol Exp Ther; 1992 May 31; 261(2):447-53. PubMed ID: 1349640
    [Abstract] [Full Text] [Related]

  • 12. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
    Insel TR, Battaglia G, Johannessen JN, Marra S, De Souza EB.
    J Pharmacol Exp Ther; 1989 Jun 31; 249(3):713-20. PubMed ID: 2471824
    [Abstract] [Full Text] [Related]

  • 13. Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine.
    Winslow JT, Insel TR.
    J Pharmacol Exp Ther; 1990 Jul 31; 254(1):212-20. PubMed ID: 1973197
    [Abstract] [Full Text] [Related]

  • 14. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.
    Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS.
    J Pharmacol Exp Ther; 1987 Apr 31; 241(1):338-45. PubMed ID: 2883295
    [Abstract] [Full Text] [Related]

  • 15. Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity.
    Brodkin J, Malyala A, Nash JF.
    Pharmacol Biochem Behav; 1993 Jul 31; 45(3):647-53. PubMed ID: 8101380
    [Abstract] [Full Text] [Related]

  • 16. Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons.
    Higuchi M, Suzuki Y, Yatani Y, Kitagawa Y, Nagayasu K, Shirakawa H, Nakagawa T, Kaneko S.
    J Neurochem; 2008 Sep 31; 106(6):2410-20. PubMed ID: 18662325
    [Abstract] [Full Text] [Related]

  • 17. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P, Arbilla S, Cantrill RC, Scatton B, Langer SZ.
    J Pharmacol Exp Ther; 1985 Oct 31; 235(1):220-9. PubMed ID: 3930699
    [Abstract] [Full Text] [Related]

  • 18. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.
    Sprague JE, Nichols DE.
    J Pharmacol Exp Ther; 1995 May 31; 273(2):667-73. PubMed ID: 7538579
    [Abstract] [Full Text] [Related]

  • 19. Long-term alteration in the central monoaminergic systems of the rat by 2,4,5-trihydroxyamphetamine but not by 2-hydroxy-4,5-methylenedioxymethamphetamine or 2-hydroxy-4,5-methylenedioxyamphetamine.
    Elayan I, Gibb JW, Hanson GR, Foltz RL, Lim HK, Johnson M.
    Eur J Pharmacol; 1992 Oct 20; 221(2-3):281-8. PubMed ID: 1358654
    [Abstract] [Full Text] [Related]

  • 20. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain.
    Darvesh AS, Yamamoto BK, Gudelsky GA.
    J Pharmacol Exp Ther; 2005 Feb 20; 312(2):694-701. PubMed ID: 15456837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.